|
|
 |
|
Viewing report
|
|
 |
 |
Arthritis in the United States
Mintel, June 2007
This report covers the prevalence, incidence, costs, causes, prevention, and treatments of arthritis. Comprised of more than 100 distinct conditions, Arthritis affects approximately 50 million Americans. There are seven different drug classes (including over-the-counter and prescription medications) that treat various types of arthritis. In spite of the variety of options available, the need continues for new alternatives.
This report provides rates of use for a wide array of treatments, including traditional medications, herbal remedies, therapies, and activities to reduce pain and fatigue and increase mobility.
Specifically, this report features in-depth discussions of:
-The prevalence and costs of arthritis in its many forms
-Causes and preventative behavior
-The multitude of medical practitioners treating arthritic patients, including mainstream doctors such as rheumatologists, orthopedists, and osteopaths; as well as alternative medical professionals such as chiropractors, massage therapists, and acupuncturists
-The treatments patients use to alleviate suffering and stop the progress of disease, ranging from pharmaceuticals to herbal remedies to therapies such as aquatic and temperature therapies
-Attitudes and opinions of arthritis sufferers from analysis of the Simmons NCS and Mintel’s own exclusive fieldwork, focusing on condition prevalence, medication preferences, attitudes towards alternative remedies, condition severity rankings, specific sites of localized pain, and ethnic attitudes towards arthritis
-Mintel also identifies key trends in the future of arthritis, including prevalence, treatment, and diagnosis.
Customers who bought this item also bought
Arthritis in the United States
Pipeline Insight: Rheumatoid Arthritis and Osteoarthritis - Striving for innovation among me-toos
Arthritis and Osteoporosis: 2006 Trends & Treatments
Osteoarthritis and Rheumatoid Arthritis: Opinion Leader Forum - Experts Views and Perspectives on Diagnosis, Treatment, Product Performance and Closing the Need Gap
Drugs of Tomorrow 2000: Arthritis - Developments For a Competitive Market
Rheumatoid arthritis: Emerging drug discovery targets and therapeutic candidates
Epidemiology: Osteo and Rheumatoid Arthritis - Defining the patient populations
Treatment Algorithms: Rheumatoid Arthritis 2nd Edition - Dmards Move to Front of Pack
|
 |
|
|